Lipid efflux mechanisms, relation to disease and potential therapeutic aspects

Sharrett, 2001, Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the atherosclerosis risk in communities (ARIC) Study, Circulation., 104, 1108, 10.1161/hc3501.095214

Glomset, 1966, Role of plasma lecithin: cholesterol acyltransferase in the metabolism of high density lipoproteins, J. Lipid Res., 7, 638, 10.1016/S0022-2275(20)39245-2

de la Llera-Moya, 2010, The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages, Arterioscler. Thromb. Vasc. Biol., 30, 796, 10.1161/ATVBAHA.109.199158

Teslovich, 2010, Biological, clinical and population relevance of 95 loci for blood lipids, Nature, 466, 707, 10.1038/nature09270

Voight, 2012, Plasma HDL-C and risk of myocardial infarction: a mendelian randomisation study, Lancet (London, England), 380, 572, 10.1016/S0140-6736(12)60312-2

Holmes, 2015, Mendelian randomization of blood lipids for coronary heart disease, Eur. Heart J., 36, 539, 10.1093/eurheartj/eht571

Barter, 2007, Effects of torcetrapib in patients at high risk for coronary events, N. Engl. J. Med., 357, 2109, 10.1056/NEJMoa0706628

Boden, 2011, Niacin in patients with low HDL-C levels receiving intensive statin therapy, N. Engl. J. Med., 365, 2255, 10.1056/NEJMoa1107579

Schwartz, 2012, Effects of dalcetrapib in patients with a recent acute coronary syndrome, N. Engl. J. Med., 367, 2089, 10.1056/NEJMoa1206797

2013, HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment, Eur. Heart J., 34, 1279, 10.1093/eurheartj/eht055

Castro, 1988, Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein, Biochemistry., 27, 25, 10.1021/bi00401a005

Farbstein, 2012, HDL dysfunction in diabetes: causes and possible treatments, Expert. Rev. Cardiovasc. Ther., 10, 353, 10.1586/erc.11.182

Khalil, 2012, Impairment of the ABCA1 and SR-BI-mediated cholesterol efflux pathways and HDL anti-inflammatory activity in Alzheimer's disease, Mech. Ageing Dev., 133, 20, 10.1016/j.mad.2011.11.008

Camponova, 2017, Alteration of high-density lipoprotein functionality in Alzheimer's disease patients, Can. J. Physiol. Pharmacol., 95, 894, 10.1139/cjpp-2016-0710

Kontush, 2012

Phillips, 2014, Molecular mechanisms of cellular cholesterol efflux, J. Biol. Chem., 289, 24020, 10.1074/jbc.R114.583658

De Lalla, 1954, Ultracentrifugal analysis of serum lipoproteins, Methods Biochem. Anal., 1, 459, 10.1002/9780470110171.ch16

Nichols, 1986, Nondenaturing polyacrylamide gradient gel electrophoresis, 417

Kontush, 2015, Structure of HDL: particle subclasses and olecular components, Handb. Exp. Pharmacol., 224, 3, 10.1007/978-3-319-09665-0_1

Rosenson, 2012, Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport, Circulation., 125, 1905, 10.1161/CIRCULATIONAHA.111.066589

Heinecke, 2009, The HDL proteome: a marker--and perhaps mediator--of coronary artery disease, J. Lipid Res., 50, S167, 10.1194/jlr.R800097-JLR200

Hoofnagle, 2009, Lipoproteomics: using mass spectrometry-based proteomics to explore the assembly, structure, and function of lipoproteins, J. Lipid Res., 50, 1967, 10.1194/jlr.R900015-JLR200

Davidsson, 2010, Proteomics of apolipoproteins and associated proteins from plasma high-density lipoproteins, Arterioscler. Thromb. Vasc. Biol., 30, 156, 10.1161/ATVBAHA.108.179317

Shah, 2013, Davidson, proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond, J. Lipid Res., 54, 2575, 10.1194/jlr.R035725

Rosenson, 2011, HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events, Clin. Chem., 57, 392, 10.1373/clinchem.2010.155333

Huang, 2011, Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma, Nat. Struct. Mol. Biol., 18, 416, 10.1038/nsmb.2028

Sieber, 2012, Coordination of triacylglycerol and cholesterol homeostasis by DHR96 and the Drosophila LipA homolog magro, Cell Metab., 15, 122, 10.1016/j.cmet.2011.11.011

Babin, 1997, Both apolipoprotein E and A-I genes are present in a nonmammalian vertebrate and are highly expressed during embryonic development, Proc. Natl. Acad. Sci. U. S. A., 94, 8622, 10.1073/pnas.94.16.8622

Dietschy, 2002, Control of cholesterol turnover in the mouse, J. Biol. Chem., 277, 3801, 10.1074/jbc.R100057200

Rader, 2009, The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis, J. Lipid Res., 50, S189, 10.1194/jlr.R800088-JLR200

Ouimet, 2019, HDL and reverse cholesterol transport: basic mechanisms and their roles in vascular health and disease, Circ. Res., 124, 1505, 10.1161/CIRCRESAHA.119.312617

Hellerstein, 2014, Reverse cholesterol transport fluxes, Curr. Opin. Lipidol., 25, 40, 10.1097/MOL.0000000000000050

Marques, 2018, Reverse cholesterol transport: molecular mechanisms and the non-medical approach to enhance HDL-C, Front. Physiol., 9, 526, 10.3389/fphys.2018.00526

Singaraja, 2006, Both hepatic and extrahepatic ABCA1 have discrete and essential functions in the maintenance of plasma high-density lipoprotein cholesterol levels in vivo, Circulation, 114, 1301, 10.1161/CIRCULATIONAHA.106.621433

Brunham, 2006, Intestinal ABCA1 directly contributes to HDL biogenesis in vivo, J. Clin. Invest., 116, 1052, 10.1172/JCI27352

Wang, 2007, Molecular regulation of macrophage reverse cholesterol transport, Curr. Opin. Cardiol., 22, 368, 10.1097/HCO.0b013e3281ec5113

Fisher, 2012, High-density lipoprotein function, dysfunction, and reverse cholesterol transport, Arterioscler. Thromb. Vasc. Biol., 32, 2813, 10.1161/ATVBAHA.112.300133

Tall, 2015, Cholesterol, inflammation and innate immunity, Nat. Rev. Immunol., 15, 104, 10.1038/nri3793

Jonas, 2000, Lecithin cholesterol acyltransferase, Biochim. Biophys. Acta, 1529, 245, 10.1016/S1388-1981(00)00153-0

Kostner, 1972, Composition and structure of plasma lipoproteins. Separation and quantification of the lipoprotein families occurring in the high density lipoproteins of human plasma, Biochemistry., 11, 3419, 10.1021/bi00768a015

Acton, 1996, Identification of scavenger receptor SR-BI as a high density lipoprotein receptor, Science., 271, 518, 10.1126/science.271.5248.518

Krieger, 1999, Charting the fate of the “good cholesterol”: identification and characterization of the high-density lipoprotein receptor SR-BI, Annu. Rev. Biochem., 68, 523, 10.1146/annurev.biochem.68.1.523

Martinez, 2003, Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis, Nature., 421, 75, 10.1038/nature01250

Fabre, 2010, P2Y13 receptor is critical for reverse cholesterol transport, Hepatology., 52, 1477, 10.1002/hep.23897

Serhan, 2013, Chronic pharmacological activation of P2Y13 receptor in mice decreases HDL-cholesterol level by increasing hepatic HDL uptake and bile acid secretion, Biochim. Biophys. Acta, 1831, 719, 10.1016/j.bbalip.2012.12.006

Vladimirov, 2017, Influence of LCAT and CETP activity on the reverse cholesterol transport and modification of HDL particles in statin-treated coronary artery disease patients and healthy subjects, Atherosclerosis., 263, 10.1016/j.atherosclerosis.2017.06.708

Tanigawa, 2007, Expression of cholesteryl ester transfer protein in mice promotes macrophage reverse cholesterol transport, Circulation., 116, 1267, 10.1161/CIRCULATIONAHA.107.704254

Osono, 1996, Centripetal cholesterol flux from extrahepatic organs to the liver is independent of the concentration of high density lipoprotein-cholesterol in plasma, Proc. Natl. Acad. Sci. U. S. A., 93, 4114, 10.1073/pnas.93.9.4114

Castro-Perez, 2011, Anacetrapib promotes reverse cholesterol transport and bulk cholesterol excretion in Syrian golden hamsters, J. Lipid Res., 52, 1965, 10.1194/jlr.M016410

Barter, 2003, Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis, Arterioscler. Thromb. Vasc. Biol., 23, 160, 10.1161/01.ATV.0000054658.91146.64

Hogarth, 2003, Genomic evidence for the absence of a functional cholesteryl ester transfer protein gene in mice and rats, Comp. Biochem. Physiol. B. Biochem. Mol. Biol., 135, 219, 10.1016/S1096-4959(03)00046-0

Vrins, 2012, Trans-intestinal cholesterol efflux is not mediated through high density lipoprotein, J. Lipid Res., 53, 2017, 10.1194/jlr.M022194

Annema, 2012, Regulation of reverse cholesterol transport - A comprehensive appraisal of available animal studies, Nutr. Metab. (Lond)., 9, 25, 10.1186/1743-7075-9-25

Li, 2013, ATP-binding cassette transporters and cholesterol translocation, IUBMB Life, 65, 505, 10.1002/iub.1165

Altemus, 2014, Liver-specific induction of Abcg5 and Abcg8 stimulates reverse cholesterol transport in response to ezetimibe treatment, Metabolism., 63, 1334, 10.1016/j.metabol.2014.06.014

Groen, 2008, Abcg5/8 independent biliary cholesterol excretion in Atp8b1-deficient mice, Gastroenterology., 134, 2091, 10.1053/j.gastro.2008.02.097

Silver, 2001, High density lipoprotein (HDL) particle uptake mediated by scavenger receptor class B type 1 results in selective sorting of HDL-C from protein and polarized cholesterol secretion, J. Biol. Chem., 276, 25287, 10.1074/jbc.M101726200

Dikkers, 2013, Scavenger receptor BI and ABCG5/G8 differentially impact biliary sterol secretion and reverse cholesterol transport in mice, Hepatology., 58, 293, 10.1002/hep.26316

Vrins, 2007, The sterol transporting heterodimer ABCG5/ABCG8 requires bile salts to mediate cholesterol efflux, FEBS Lett., 581, 4616, 10.1016/j.febslet.2007.08.052

Temel, 2010, Biliary sterol secretion is not required for macrophage reverse cholesterol transport, Cell Metab., 12, 96, 10.1016/j.cmet.2010.05.011

Kruit, 2005, Increased fecal neutral sterol loss upon liver X receptor activation is independent of biliary sterol secretion in mice, Gastroenterology., 128, 147, 10.1053/j.gastro.2004.10.006

van der Velde, 2007, Direct intestinal cholesterol secretion contributes significantly to total fecal neutral sterol excretion in mice, Gastroenterology., 133, 967, 10.1053/j.gastro.2007.06.019

Brown, 2008, Targeted depletion of hepatic ACAT2-driven cholesterol esterification reveals a non-biliary route for fecal neutral sterol loss, J. Biol. Chem., 283, 10522, 10.1074/jbc.M707659200

van der Veen, 2009, Activation of the liver X receptor stimulates trans-intestinal excretion of plasma cholesterol, J. Biol. Chem., 284, 19211, 10.1074/jbc.M109.014860

Temel, 2012, Biliary and nonbiliary contributions to reverse cholesterol transport, Curr. Opin. Lipidol., 23, 85, 10.1097/MOL.0b013e3283508c21

Tietge, 2013, Role the TICE?: advancing the concept of transintestinal cholesterol excretion, Arterioscler. Thromb. Vasc. Biol., 33, 1452, 10.1161/ATVBAHA.113.301562

van der Velde, 2010, Transintestinal cholesterol efflux, Curr. Opin. Lipidol., 21, 167, 10.1097/MOL.0b013e3283395e45

Kruit, 2006, Emerging roles of the intestine in control of cholesterol metabolism, World J. Gastroenterol., 12, 6429, 10.3748/wjg.v12.i40.6429

Paalvast, 2017, Developments in intestinal cholesterol transport and triglyceride absorption, Curr. Opin. Lipidol., 28, 248, 10.1097/MOL.0000000000000415

Cheng, 1959, Secretion of cholesterol by intestinal mucosa in patients with complete common bile duct obstruction, Proc. Soc. Exp. Biol. Med., 101, 223, 10.3181/00379727-101-24890

Stanley, 1959, Serum cholesteryl esters and intestinal cholesterol secretion and absorption in obstructive jaundice due to cancer, N. Engl. J. Med., 261, 368, 10.1056/NEJM195908202610802

Zhang, 2003, Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo, Circulation., 108, 661, 10.1161/01.CIR.0000086981.09834.E0

Véniant, 1998, Lipoprotein clearance mechanisms in LDL receptor-deficient “Apo-B48-only” and “Apo-B100-only” mice, J. Clin. Invest., 102, 1559, 10.1172/JCI4164

Vedhachalam, 2010, Influence of apolipoprotein (Apo) A-I structure on nascent high density lipoprotein (HDL) particle size distribution, J. Biol. Chem., 285, 31965, 10.1074/jbc.M110.126292

Lyssenko, 2012, Influence of C-terminal α-helix hydrophobicity and aromatic amino acid content on apolipoprotein A-I functionality, Biochim. Biophys. Acta, 1821, 456, 10.1016/j.bbalip.2011.07.020

Fielding, 2008, 18

Robichaud, 2019, Quantifying Cellular Cholesterol Efflux, Methods Mol. Biol., 1951, 111, 10.1007/978-1-4939-9130-3_9

Favari, 2015, Cholesterol efflux and reverse cholesterol transport, 181

Yancey, 2003, Importance of different pathways of cellular cholesterol efflux, Arterioscler. Thromb. Vasc. Biol., 23, 712, 10.1161/01.ATV.0000057572.97137.DD

Schou, 2012, Genetic variation in ABCG1 and risk of myocardial infarction and ischemic heart disease, Arterioscler. Thromb. Vasc. Biol., 32, 506, 10.1161/ATVBAHA.111.234872

Huang, 2015, The role of the lymphatic system in cholesterol transport, Front. Pharmacol., 6, 1, 10.3389/fphar.2015.00182

Adorni, 2007, The roles of different pathways in the release of cholesterol from macrophages, J. Lipid Res., 48, 2453, 10.1194/jlr.M700274-JLR200

Tabas, 2015, Recent insights into the cellular biology of atherosclerosis, J. Cell Biol., 209, 13, 10.1083/jcb.201412052

Ceccanti, 2016, A novel mutation in ABCA1 gene causing tangier disease in an Italian family with uncommon neurological presentation, Front. Neurol., 7, 1, 10.3389/fneur.2016.00185

Singaraja, 2003, Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene, Arterioscler. Thromb. Vasc. Biol., 23, 1322, 10.1161/01.ATV.0000078520.89539.77

Frikke-Schmidt, 2008, Genetic variation in ABCA1 predicts ischemic heart disease in the general population, Arterioscler. Thromb. Vasc. Biol., 28, 180, 10.1161/ATVBAHA.107.153858

Frikke-Schmidt, 2005, Mutation in ABCA1 predicted risk of ischemic heart disease in the Copenhagen City heart Study population, J. Am. Coll. Cardiol., 46, 1516, 10.1016/j.jacc.2005.06.066

Frikke-Schmidt, 2008, Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease, JAMA., 299, 2524, 10.1001/jama.299.21.2524

Costet, 2000, Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor, J. Biol. Chem., 275, 28240, 10.1074/jbc.M003337200

Hu, 2010, TGF-beta1 up-regulates expression of ABCA1, ABCG1 and SR-BI through liver X receptor alpha signaling pathway in THP-1 macrophage-derived foam cells, J. Atheroscler. Thromb., 17, 493, 10.5551/jat.3152

Adorni, 2017, Inhibitory effect of PCSK9 on Abca1 protein expression and cholesterol efflux in macrophages, Atherosclerosis., 256, 1, 10.1016/j.atherosclerosis.2016.11.019

Coban, 2017, CYP19A1, MIF and ABCA1 genes are targets of the RORalpha in monocyte and endothelial cells, Cell Biol. Int., 41, 163, 10.1002/cbin.10712

Porsch-Ozcurumez, 2001, The zinc finger protein 202 (ZNF202) is a transcriptional repressor of ATP binding cassette transporter A1 (ABCA1) and ABCG1 gene expression and a modulator of cellular lipid efflux, J. Biol. Chem., 276, 12427, 10.1074/jbc.M100218200

Lyu, 2016, Insulin-like Growth Factor 1 Regulates the Expression of ATP-Binding Cassette Transporter A1 in Pancreatic Beta Cells, Horm. Metab., 48, 338, 10.1055/s-0035-1569272

Wang, 2003, A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I, J. Clin. Invest., 111, 99, 10.1172/JCI200316808

Iwamoto, 2010, Calmodulin interacts with ATP binding cassette transporter A1 to protect from calpain-mediated degradation and upregulates high-density lipoprotein generation, Arterioscler. Thromb. Vasc. Biol., 30, 1446, 10.1161/ATVBAHA.110.203927

Chang, 2013, Hyperglycemia accelerates ATP-binding cassette transporter A1 degradation via an ERK-dependent pathway in macrophages, J. Cell. Biochem., 114, 1364, 10.1002/jcb.24478

Do, 2019, Integration of miRNA weighted gene co-expression network and miRNA-mRNA co-expression analyses reveals potential regulatory functions of miRNAs in calf rumen development, Genomics., 111, 849, 10.1016/j.ygeno.2018.05.009

Fernández-Hernando, 2011, MicroRNAs in lipid metabolism, Curr. Opin. Lipidol., 22, 86, 10.1097/MOL.0b013e3283428d9d

Tan, 2019, Inhibition of microRNA-17-5p reduces the inflammation and lipid accumulation, and up-regulates ATP-binding cassette transporterA1 in atherosclerosis, J. Pharmacol. Sci., 139, 280, 10.1016/j.jphs.2018.11.012

Kim, 2017, MicroRNA 18a is a novel regulator of reverse cholesterol transport and potential therapeutic targets in atherosclerosis, Atherosclerosis., 263, e111, 10.1016/j.atherosclerosis.2017.06.358

Yang, 2018, MicroRNA-23a-5p promotes atherosclerotic plaque progression and vulnerability by repressing ATP-binding cassette transporter A1/G1 in macrophages, J. Mol. Cell. Cardiol., 123, 139, 10.1016/j.yjmcc.2018.09.004

Rayner, 2011, Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides, Nature., 478, 404, 10.1038/nature10486

Rottiers, 2013, Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiR, Sci. Transl. Med., 5, 212ra162, 10.1126/scitranslmed.3006840

Wagschal, 2015, Genome-wide identification of microRNAs regulating cholesterol and triglyceride homeostasis, Nat. Med., 21, 1290, 10.1038/nm.3980

Quazi, 2013, Differential phospholipid substrates and directional transport by ATP-binding cassette proteins ABCA1, ABCA7, and ABCA4 and disease-causing mutants, J. Biol. Chem., 288, 34414, 10.1074/jbc.M113.508812

Gillotte, 1998, Removal of cellular cholesterol by pre-beta-HDL involves plasma membrane microsolubilization, J. Lipid Res., 39, 1918, 10.1016/S0022-2275(20)32490-1

Wang, 2001, ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein, J. Biol. Chem., 276, 23742, 10.1074/jbc.M102348200

Wang, 2003, ATP-binding cassette transporter A7 (ABCA7) binds apolipoprotein a-I and mediates cellular phospholipid but not cholesterol efflux, J. Biol. Chem., 278, 42906, 10.1074/jbc.M307831200

Vedhachalam, 2007, Mechanism of ATP-binding cassette transporter A1-mediated cellular lipid efflux to apolipoprotein a-I and formation of high density lipoprotein particles, J. Biol. Chem., 282, 25123, 10.1074/jbc.M704590200

Nagata, 2013, ABCA1 dimer-monomer interconversion during HDL generation revealed by single-molecule imaging, Proc. Natl. Acad. Sci. U. S. A., 110, 5034, 10.1073/pnas.1220703110

Chen, 2001, Preferential ATP-binding cassette transporter A1-mediated cholesterol efflux from late endosomes/lysosomes, J. Biol. Chem., 276, 43564, 10.1074/jbc.M107938200

Singaraja, 2009, Palmitoylation of ATP-binding cassette transporter A1 is essential for its trafficking and function, Circ. Res., 105, 138, 10.1161/CIRCRESAHA.108.193011

Shen, 2018, SR-BI: a unique multifunctional receptor for cholesterol influx and efflux, Annu. Rev. Physiol., 80, 95, 10.1146/annurev-physiol-021317-121550

Gelissen, 2006, ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I, Arterioscler. Thromb. Vasc. Biol., 26, 534, 10.1161/01.ATV.0000200082.58536.e1

Hegyi, 2016, Functional Cooperativity between ABCG4 and ABCG1 isoforms, PLoS One, 11, 10.1371/journal.pone.0156516

Gelissen, 2010, Expression and stability of two isoforms of ABCG1 in human vascular cells, Atherosclerosis., 208, 75, 10.1016/j.atherosclerosis.2009.06.028

Nakamura, 2004, Expression and regulation of multiple murine ATP-binding cassette transporter G1 mRNAs/isoforms that stimulate cellular cholesterol efflux to high density lipoprotein, J. Biol. Chem., 279, 45980, 10.1074/jbc.M408652200

Chen, 1996, Cloning of the cDNA for a human homologue of the Drosophila white gene and mapping to chromosome 21q22.3, Am. J. Hum. Genet., 59, 66

Tarling, 2011, ATP binding cassette transporter G1 (ABCG1) is an intra-cellular sterol transporter, Proc. Natl. Acad. Sci. U. S. A., 108, 19719, 10.1073/pnas.1113021108

Harris, 2018, Reinterpretation of the localization of the ATP binding cassette transporter ABCG1 in insulin-secreting cells and insights regarding its trafficking and function, PLoS One, 13, 10.1371/journal.pone.0198383

Gu, 2016, Identification of an amino acid residue critical for plasma membrane localization of ATP-binding cassette transporter G1--brief report, Arterioscler. Thromb. Vasc. Biol., 36, 253, 10.1161/ATVBAHA.115.306592

Vaughan, 2005, ABCG1 redistributes cell cholesterol to domains removable by high density lipoprotein but not by lipid-depleted apolipoproteins, J. Biol. Chem., 280, 30150, 10.1074/jbc.M505368200

Wang, 2006, LXR-induced redistribution of ABCG1 to plasma membrane in macrophages enhances cholesterol mass efflux to HDL, Arterioscler. Thromb. Vasc. Biol., 26, 1310, 10.1161/01.ATV.0000218998.75963.02

Tarling, 2016, Intra-cellular Localization of Endogenous Mouse ABCG1 Is Mimicked by Both ABCG1-L550 and ABCG1-P550-Brief Report, Arterioscler. Thromb. Vasc. Biol., 36, 1323, 10.1161/ATVBAHA.116.307414

Larrede, 2009, Stimulation of cholesterol efflux by LXR agonists in cholesterol-loaded human macrophages is ABCA1-dependent but ABCG1-independent, Arterioscler. Thromb. Vasc. Biol., 29, 1930, 10.1161/ATVBAHA.109.194548

Klucken, 2000, ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport, Proc. Natl. Acad. Sci., 97, 817, 10.1073/pnas.97.2.817

Kennedy, 2001, Characterization of the human ABCG1 gene: liver X receptor activates an internal promoter that produces a novel transcript encoding an alternative form of the protein, J. Biol. Chem., 276, 39438, 10.1074/jbc.M105863200

Rayner, 2011, Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis, J. Clin. Invest., 121, 2921, 10.1172/JCI57275

Hardy, 2017, Critical role of the human ATP-binding cassette G1 transporter in cardiometabolic diseases, Int. J. Mol. Sci., 18, 1, 10.3390/ijms18091892

Tavoosi, 2015, Cholesterol transporters ABCA1 and ABCG1 gene expression in peripheral blood mononuclear cells in patients with metabolic syndrome, Cholesterol., 2015, 1, 10.1155/2015/682904

Terasaka, 2007, High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1, Proc. Natl. Acad. Sci. U. S. A., 104, 15093, 10.1073/pnas.0704602104

Engel, 2007, Expression of ATP binding cassette-transporter ABCG1 prevents cell death by transporting cytotoxic 7beta-hydroxycholesterol, FEBS Lett., 581, 1673, 10.1016/j.febslet.2007.03.038

Li, 2010, Adenosine monophosphate activated protein kinase regulates ABCG1-mediated oxysterol efflux from endothelial cells and protects against hypercholesterolemia-induced endothelial dysfunction, Arterioscler. Thromb. Vasc. Biol., 30, 1354, 10.1161/ATVBAHA.110.204230

Engel, 2014, 3beta,5alpha,6beta-Cholestanetriol and 25-hydroxycholesterol accumulate in ATP-binding cassette transporter G1 (ABCG1)-deficiency, Atherosclerosis., 235, 122, 10.1016/j.atherosclerosis.2014.04.023

Kobayashi, 2006, Efflux of sphingomyelin, cholesterol, and phosphatidylcholine by ABCG1, J. Lipid Res., 47, 1791, 10.1194/jlr.M500546-JLR200

Neufeld, 2014, The Human ABCG1 Transporter Mobilizes Plasma Membrane and Late Endosomal Non-Sphingomyelin-Associated-Cholesterol for Efflux and Esterification, Biology (Basel), 3, 866

Out, 2006, Macrophage ABCG1 deletion disrupts lipid homeostasis in alveolar macrophages and moderately influences atherosclerotic lesion development in LDL receptor-deficient mice, Arterioscler. Thromb. Vasc. Biol., 26, 2295, 10.1161/01.ATV.0000237629.29842.4c

Baldan, 2006, Impaired development of atherosclerosis in hyperlipidemic Ldlr−/− and ApoE−/− mice transplanted with Abcg1−/− bone marrow, Arterioscler. Thromb. Vasc. Biol., 26, 2301, 10.1161/01.ATV.0000240051.22944.dc

Ranalletta, 2006, Decreased atherosclerosis in low-density lipoprotein receptor knockout mice transplanted with Abcg1−/− bone marrow, Arterioscler. Thromb. Vasc. Biol., 26, 2308, 10.1161/01.ATV.0000242275.92915.43

Out, 2008, Combined deletion of macrophage ABCA1 and ABCG1 leads to massive lipid accumulation in tissue macrophages and distinct atherosclerosis at relatively low plasma cholesterol levels, Arterioscler. Thromb. Vasc. Biol., 28, 258, 10.1161/ATVBAHA.107.156935

Ruud, 2008, Combined Deletion of Macrophage ABCA1 and ABCG1 Leads to Massive Lipid Accumulation in Tissue Macrophages and Distinct Atherosclerosis at Relatively Low Plasma Cholesterol Levels, Arterioscler. Thromb. Vasc. Biol., 28, 258, 10.1161/ATVBAHA.107.156935

Vaughan, 2006, ABCA1 and ABCG1 or ABCG4 act sequentially to remove cellular cholesterol and generate cholesterol-rich HDL, J. Lipid Res., 47, 2433, 10.1194/jlr.M600218-JLR200

Shen, 2018, Scavenger receptor B type 1: expression, molecular regulation, and cholesterol transport function, J. Lipid Res., 59, 1114, 10.1194/jlr.R083121

Danilo, 2013, Scavenger receptor class B type I regulates cellular cholesterol metabolism and cell signaling associated with breast cancer development, Breast Cancer Res., 15, R87, 10.1186/bcr3483

Shen, 2014, Scavenger receptor class B type I (SR-BI): a versatile receptor with multiple functions and actions, Metabolism., 63, 875, 10.1016/j.metabol.2014.03.011

Matveev, 1999, Co-expression of scavenger receptor-BI and caveolin-1 is associated with enhanced selective cholesteryl ester uptake in THP-1 macrophages, J. Lipid Res., 40, 1647, 10.1016/S0022-2275(20)33410-6

Varban, 1998, Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol, Proc. Natl. Acad. Sci. U. S. A., 95, 4619, 10.1073/pnas.95.8.4619

Rigotti, 1997, A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism, Proc. Natl. Acad. Sci. U. S. A., 94, 12610, 10.1073/pnas.94.23.12610

Acton, 1994, Expression cloning of SR-BI, a CD36-related class B scavenger receptor, J. Biol. Chem., 269, 21003, 10.1016/S0021-9258(17)31921-X

Van Eck, 2004, Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerotic lesion development, Am. J. Pathol., 165, 785, 10.1016/S0002-9440(10)63341-X

Hirano, 1999, Expression of human scavenger receptor class B type I in cultured human monocyte-derived macrophages and atherosclerotic lesions, Circ. Res., 85, 108, 10.1161/01.RES.85.1.108

Zhao, 2010, Enhanced foam cell formation, atherosclerotic lesion development, and inflammation by combined deletion of ABCA1 and SR-BI in bone marrow-derived cells in LDL receptor knockout mice on western-type diet, Circ. Res., 107, e20, 10.1161/CIRCRESAHA.110.226282

Zhang, 2003, Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice, Circulation., 108, 2258, 10.1161/01.CIR.0000093189.97429.9D

Covey, 2003, Scavenger receptor class B type I-mediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells, Arterioscler. Thromb. Vasc. Biol., 23, 1589, 10.1161/01.ATV.0000083343.19940.A0

de la Llera-Moya, 1999, Scavenger receptor BI (SR-BI) mediates free cholesterol flux independently of HDL tethering to the cell surface, J. Lipid Res., 40, 575, 10.1016/S0022-2275(20)32462-7

Kellner-Weibel, 2000, Expression of scavenger receptor BI in COS-7 cells alters cholesterol content and distribution, Biochemistry., 39, 221, 10.1021/bi991666c

Thuahnai, 2004, Scavenger receptor class B type I-mediated cholesteryl ester-selective uptake and efflux of unesterified cholesterol. Influence of high density lipoprotein size and structure, J. Biol. Chem., 279, 12448, 10.1074/jbc.M311718200

Williams, 1999, Scavenger receptor BI and cholesterol trafficking, Curr. Opin. Lipidol., 10, 329, 10.1097/00041433-199908000-00007

Yancey, 2000, High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI, J. Biol. Chem., 275, 36596, 10.1074/jbc.M006924200

Phillips, 1987, Mechanisms and consequences of cellular cholesterol exchange and transfer, Biochim. Biophys. Acta, 906, 223, 10.1016/0304-4157(87)90013-X

Schroeder, 1991, Membrane cholesterol dynamics: cholesterol domains and kinetic pools, Proc. Soc. Exp. Biol. Med., 196, 235, 10.3181/00379727-196-43185

Davidson, 1995, Effects of acceptor particle size on the efflux of cellular free cholesterol, J. Biol. Chem., 270, 17106, 10.1074/jbc.270.29.17106

Schroeder, 1995, Cholesterol domains in biological membranes, Mol. Membr. Biol., 12, 113, 10.3109/09687689509038505

Mahlberg, 1992, Cellular cholesterol efflux. Role of cell membrane kinetic pools and interaction with apolipoproteins AI, AII, and Cs, J. Biol. Chem., 267, 4541, 10.1016/S0021-9258(18)42867-0

McIntosh, 1995, Experimental tests for protrusion and undulation pressures in phospholipid bilayers, Biochemistry, 34, 8520, 10.1021/bi00027a002

Zhao, 1996, Serum albumin is a significant intermediate in cholesterol transfer between cells and lipoproteins, Biochemistry., 35, 7174, 10.1021/bi952242v

Lund-Katz, 1988, Influence of molecular packing and phospholipid type on rates of cholesterol exchange, Biochemistry., 27, 3416, 10.1021/bi00409a044

Aiello, 2002, Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages, Arterioscler. Thromb. Vasc. Biol., 22, 630, 10.1161/01.ATV.0000014804.35824.DA

Hoekstra, 2015, Mouse models of disturbed HDL metabolism, Handb. Exp. Pharmacol., 224, 301, 10.1007/978-3-319-09665-0_9

Sturek, 2010, An intra-cellular role for ABCG1-mediated cholesterol transport in the regulated secretory pathway of mouse pancreatic beta cells, J. Clin. Invest., 120, 2575, 10.1172/JCI41280

Kruit, 2012, Loss of both ABCA1 and ABCG1 results in increased disturbances in islet sterol homeostasis, inflammation, and impaired beta-cell function, Diabetes., 61, 659, 10.2337/db11-1341

Vergeer, 2010, Carriers of loss-of-function mutations in ABCA1 display pancreatic beta-cell dysfunction, Diabetes Care, 33, 869, 10.2337/dc09-1562

Koseki, 2009, Impaired insulin secretion in four Tangier disease patients with ABCA1 mutations, J. Atheroscler. Thromb., 16, 292, 10.5551/jat.E599

Schou, 2012, ABC transporter genes and risk of type 2 diabetes: a study of 40,000 individuals from the general population, Diabetes Care, 35, 2600, 10.2337/dc12-0082

Rickels, 2015, Loss-of-function mutations in ABCA1 and enhanced beta-cell secretory capacity in young adults, Diabetes., 64, 193, 10.2337/db14-0436

Hirsch-Reinshagen, 2004, Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain, J. Biol. Chem., 279, 41197, 10.1074/jbc.M407962200

Robert, 2016, Reconstituted high-density lipoproteins acutely reduce soluble brain Abeta levels in symptomatic APP/PS1 mice, Biochim. Biophys. Acta, 1862, 1027, 10.1016/j.bbadis.2015.10.005

Kasikara, 2018, The role of non-resolving inflammation in atherosclerosis, J. Clin. Invest., 128, 2713, 10.1172/JCI97950

Endo, 2010, A historical perspective on the discovery of statins, Proc. Jpn. Acad. Ser. B. Phys. Biol. Sci., 86, 484, 10.2183/pjab.86.484

Baigent, 2005, Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins, Lancet (London, England), 366, 1267, 10.1016/S0140-6736(05)67394-1

Kearney, 2008, Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis, Lancet (London, England)., 371, 117, 10.1016/S0140-6736(08)60104-X

Castelli, 1977, HDL-C and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study, Circulation, 55, 767, 10.1161/01.CIR.55.5.767

Gordon, 1989, High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies, Circulation, 79, 8, 10.1161/01.CIR.79.1.8

Nissen, 2003, Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial, JAMA., 290, 2292, 10.1001/jama.290.17.2292

Plump, 1994, Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse, Proc. Natl. Acad. Sci. U. S. A., 91, 9607, 10.1073/pnas.91.20.9607

Rubin, 1991, Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI, Nature., 353, 265, 10.1038/353265a0

Barter, 2010, Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER database, J. Lipid Res., 51, 1546, 10.1194/jlr.P002816

Mani, 2015, Niacin therapy, HDL-C, and cardiovascular disease: is the HDL hypothesis defunct?, Curr. Atheroscler. Rep., 17, 43, 10.1007/s11883-015-0521-x

Kempen, 2016, High-Density Lipoprotein Subfractions and Cholesterol Efflux Capacities After Infusion of MDCO-216 (Apolipoprotein A-IMilano/Palmitoyl-Oleoyl-Phosphatidylcholine) in Healthy Volunteers and Stable Coronary Artery Disease Patients, Arterioscler. Thromb. Vasc. Biol., 36, 736, 10.1161/ATVBAHA.115.307052

Hoekstra, 2016, Functionality of high-density lipoprotein as Antiatherosclerotic therapeutic target, Arterioscler. Thromb. Vasc. Biol., 36, e87, 10.1161/ATVBAHA.116.308262

Trigatti, 2016, Rare Genetic Variants and High-Density Lipoprotein: Marching to a Different Drum, Arterioscler. Thromb. Vasc. Biol., 36, 10.1161/ATVBAHA.116.307688

Rader, 2012, The not-so-simple HDL story: is it time to revise the HDL-C hypothesis?, Nat. Med., 18, 1344, 10.1038/nm.2937

Zanoni, 2016, Rare variant in scavenger receptor BI raises HDL-C and increases risk of coronary heart disease, Science, 351, 1166, 10.1126/science.aad3517

Goldbourt, 1979, High density lipoprotein cholesterol and incidence of coronary heart disease--the Israeli ischemic heart disease Study, Am. J. Epidemiol., 109, 296, 10.1093/oxfordjournals.aje.a112683

Stensvold, 1992, Foss, high-density lipoprotein cholesterol and coronary, cardiovascular and all cause mortality among middle-aged Norwegian men and women, Eur. Heart J., 13, 1155, 10.1093/oxfordjournals.eurheartj.a060331

de Backer, 1998, Epidemiological aspects of high density lipoprotein cholesterol, Atherosclerosis., 137, S1, 10.1016/S0021-9150(97)00310-9

Hirano, 1997, Genetic cholesteryl esters transfer protein deficiencies extremely frequent in the Omagari area of Japan, Arterioscler. Thromb. Vasc. Biol., 17, 1053, 10.1161/01.ATV.17.6.1053

Menotti, 1996, Short-term all-cause mortality and its determinants in elderly male populations in Finland, the Netherlands, and Italy: the FINE Study. Finland, Italy, Netherlands elderly Study, Prev. Med. (Baltim)., 25, 319, 10.1006/pmed.1996.0062

Madsen, 2017, Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies, Eur. Heart J., 38, 2478, 10.1093/eurheartj/ehx163

Mark, 2018, High-density lipoprotein cholesterol and mortality, Arterioscler. Thromb. Vasc. Biol., 38, 669, 10.1161/ATVBAHA.117.310587

Khera, 2011, Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis, N. Engl. J. Med., 364, 127, 10.1056/NEJMoa1001689

Rohatgi, 2014, HDL-C efflux capacity and incident cardiovascular events, N. Engl. J. Med., 371, 2383, 10.1056/NEJMoa1409065

Saleheen, 2015, Association of HDL-C efflux capacity with incident coronary heart disease events: a prospective case-control study, Lancet Diabetes Endocrinol., 3, 507, 10.1016/S2213-8587(15)00126-6

Li, 2013, Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks, Arterioscler. Thromb. Vasc. Biol., 33, 1696, 10.1161/ATVBAHA.113.301373

Ibanez, 2012, Recombinant HDL(Milano) exerts greater anti-inflammatory and plaque stabilizing properties than HDL(wild-type), Atherosclerosis., 220, 72, 10.1016/j.atherosclerosis.2011.10.006

Reijers, 2017, MDCO-216 does not induce adverse immunostimulation, in contrast to its predecessor ETC-216, Cardiovasc. Drugs Ther., 31, 381, 10.1007/s10557-017-6746-x

Tardif, 2007, Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial, JAMA., 297, 1675, 10.1001/jama.297.15.jpc70004

Gibson, 2016, Safety and Tolerability of CSL112, a reconstituted, infusible, plasma-derived apolipoprotein A-I, after acute myocardial infarction: The AEGIS-I trial (ApoA-I event reducing in ischemic syndromes I), Circulation, 134, 1918, 10.1161/CIRCULATIONAHA.116.025687

Nicholls, 2018, JAMA Cardiol., 3, 815, 10.1001/jamacardio.2018.2121

Kataoka, 2017, Regression of coronary atherosclerosis with infusions of the high-density lipoprotein mimetic CER-001 in patients with more extensive plaque burden, Cardiovasc. Diagn. Ther., 7, 252, 10.21037/cdt.2017.02.01

Shaw, 2008, Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque, Circ. Res., 103, 1084, 10.1161/CIRCRESAHA.108.182063

Gu, 1998, Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice, Mol. Cell, 2, 275, 10.1016/S1097-2765(00)80139-2

Combadiere, 2008, Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice, Circulation., 117, 1649, 10.1161/CIRCULATIONAHA.107.745091

Williams, 1995, The response-to-retention hypothesis of early therogenesis, Arterioscler. Thromb. Vasc. Biol., 15, 551, 10.1161/01.ATV.15.5.551

Steinberg, 2002, Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime, Nat. Med., 8, 1211, 10.1038/nm1102-1211

Meagher, 2000, Indices of lipid peroxidation in vivo: strengths and limitations, Free Radic. Biol. Med., 28, 1745, 10.1016/S0891-5849(00)00232-X

Gerszten, 1999, MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions, Nature., 398, 718, 10.1038/19546

Cybulsky, 1991, Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis, Science., 251, 788, 10.1126/science.1990440

An, 2008, P-selectin glycoprotein ligand-1 is highly expressed on Ly-6Chi monocytes and a major determinant for Ly-6Chi monocyte recruitment to sites of atherosclerosis in mice, Circulation., 117, 3227, 10.1161/CIRCULATIONAHA.108.771048

Li, 2002, The macrophage foam cell as a target for therapeutic intervention, Nat. Med., 8, 1235, 10.1038/nm1102-1235

Zhou, 2008, Genetic deletion of low density lipoprotein receptor impairs sterol-induced mouse macrophage ABCA1 expression. A new SREBP1-dependent mechanism, J. Biol. Chem., 283, 2129, 10.1074/jbc.M706636200

Ishibashi, 1994, Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice, J. Clin. Invest., 93, 1885, 10.1172/JCI117179

Ashraf, 2011, Scavenger receptors: implications in atherothrombotic disorders, Int. J. Biochem. Cell Biol., 43, 697, 10.1016/j.biocel.2011.01.019

Kunjathoor, 2002, Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages, J. Biol. Chem., 277, 49982, 10.1074/jbc.M209649200

Lindstedt, 1992, Soluble heparin proteoglycans released from stimulated mast cells induce uptake of low density lipoproteins by macrophages via scavenger receptor-mediated phagocytosis, J. Lipid Res., 33, 65, 10.1016/S0022-2275(20)41884-X

Anzinger, 2010, Native low-density lipoprotein uptake by macrophage colony-stimulating factor-differentiated human macrophages is mediated by macropinocytosis and micropinocytosis, Arterioscler. Thromb. Vasc. Biol., 30, 2022, 10.1161/ATVBAHA.110.210849

Anzinger, 2017, Measurement of aortic cell fluid-phase pinocytosis in vivo by flow cytometry, J. Vasc. Res., 54, 195, 10.1159/000475934

Yoshida, 2015, Differential signaling during macropinocytosis in response to M-CSF and PMA in macrophages, Front. Physiol., 6, 8, 10.3389/fphys.2015.00008

Zhang, 2018, Lysosomal acid lipase and lipid metabolism: new mechanisms, new questions, and new therapies, Curr. Opin. Lipidol., 29, 218, 10.1097/MOL.0000000000000507

Remmerie, 2018, Macrophages and lipid metabolism, Cell. Immunol., 330, 27, 10.1016/j.cellimm.2018.01.020

Kosmas, 2014, High-density lipoprotein functionality in coronary artery disease, Am J Med Sci, 347, 504, 10.1097/MAJ.0000000000000231

Cuchel, 2006, Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?, Circulation., 113, 2548, 10.1161/CIRCULATIONAHA.104.475715

Van Eck, 2006, Macrophage ATP-binding cassette transporter A1 overexpression inhibits atherosclerotic lesion progression in low-density lipoprotein receptor knockout mice, Arterioscler. Thromb. Vasc. Biol., 26, 929, 10.1161/01.ATV.0000208364.22732.16

Wang, 2007, In vivo reverse cholesterol transport from macrophages lacking ABCA1 expression is impaired, Arterioscler. Thromb. Vasc. Biol., 27, 1837, 10.1161/ATVBAHA.107.146068

Zhu, 2008, Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages, J. Biol. Chem., 283, 22930, 10.1074/jbc.M801408200

Brunham, 2009, Tissue-specific roles of ABCA1 influence susceptibility to atherosclerosis, Arterioscler. Thromb. Vasc. Biol., 29, 548, 10.1161/ATVBAHA.108.182303

Tang, 2004, Effect of apolipoprotein A-I on ATP binding cassette transporter A1 degradation and cholesterol efflux in THP-1 macrophage-derived foam cells, Acta Biochim. Biophys. Sin. (Shanghai), 36, 218, 10.1093/abbs/36.3.218

Ogura, 2011, Proteasomal inhibition promotes ATP-binding cassette transporter A1 (ABCA1) and ABCG1 expression and cholesterol efflux from macrophages in vitro and in vivo, Arterioscler. Thromb. Vasc. Biol., 31, 1980, 10.1161/ATVBAHA.111.228478

Bechor, 2016, 9-cis β-carotene increased cholesterol efflux to HDL in macrophages, Nutrients., 8, 435, 10.3390/nu8070435

Chen, 2010, Ibrolipim increases ABCA1/G1 expression by the LXRalpha signaling pathway in THP-1 macrophage-derived foam cells, Acta Pharmacol. Sin., 31, 1343, 10.1038/aps.2010.166

Tall, 2008, Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins, J. Intern. Med., 263, 256, 10.1111/j.1365-2796.2007.01898.x

Burgess, 2008, Overexpression of human ABCG1 does not affect atherosclerosis in fat-fed ApoE-deficient mice, Arterioscler. Thromb. Vasc. Biol., 28, 1731, 10.1161/ATVBAHA.108.168542

Yancey, 2007, Severely altered cholesterol homeostasis in macrophages lacking apoE and SR-BI, J. Lipid Res., 48, 1140, 10.1194/jlr.M600539-JLR200

Zhao, 2011, Hypocholesterolemia, foam cell accumulation, but no atherosclerosis in mice lacking ABC-transporter A1 and scavenger receptor BI, Atherosclerosis., 218, 314, 10.1016/j.atherosclerosis.2011.07.096

Wang, 2007, Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo, J. Clin. Invest., 117, 2216, 10.1172/JCI32057

Navab, 2004, Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice, Circulation, 109, 3215, 10.1161/01.CIR.0000134275.90823.87

Yvan-Charvet, 2008, Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions, Circulation., 118, 1837, 10.1161/CIRCULATIONAHA.108.793869

Westerterp, 2013, Deficiency of ATP-binding cassette transporters A1 and G1 in macrophages increases inflammation and accelerates atherosclerosis in mice, Circ. Res., 112, 1456, 10.1161/CIRCRESAHA.113.301086

Feig, 2014, High-density lipoprotein and atherosclerosis regression: evidence from preclinical and clinical studies, Circ. Res., 114, 205, 10.1161/CIRCRESAHA.114.300760

Khovidhunkit, 2003, Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR, J. Lipid Res., 44, 1728, 10.1194/jlr.M300100-JLR200

Shull, 1992, Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease, Nature., 359, 693, 10.1038/359693a0

Zuckerman, 1992, Cytokine regulation of macrophage apo E secretion: opposing effects of GM-CSF and TGF-beta, Atherosclerosis., 96, 203, 10.1016/0021-9150(92)90066-P

Panousis, 2001, TGF-beta increases cholesterol efflux and ABC-1 expression in macrophage-derived foam cells: opposing the effects of IFN-gamma, J. Lipid Res., 42, 856, 10.1016/S0022-2275(20)31648-5

Ramirez, 2011, MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1, Arterioscler. Thromb. Vasc. Biol., 31, 2707, 10.1161/ATVBAHA.111.232066

Sallam, 2018, Transcriptional regulation of macrophage cholesterol efflux and atherogenesis by a long noncoding RNA, Nat. Med., 24, 304, 10.1038/nm.4479

Wang, 2013, MicroRNAs 185, 96, and 223 repress selective high-density lipoprotein cholesterol uptake through posttranscriptional inhibition, Mol. Cell. Biol., 33, 1956, 10.1128/MCB.01580-12

Faggiotto, 1984, Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation, Arteriosclerosis., 4, 323, 10.1161/01.ATV.4.4.323

Vollmer, 1991, Immunohistochemical double labeling of macrophages, smooth muscle cells, and apolipoprotein E in the atherosclerotic plaque, Pathol. Res. Pract., 187, 184, 10.1016/S0344-0338(11)80769-7

Orekhov, 1998, Cell proliferation in normal and atherosclerotic human aorta: proliferative splash in lipid-rich lesions, Atherosclerosis., 139, 41, 10.1016/S0021-9150(98)00044-6

Allahverdian, 2014, Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis, Circulation., 129, 1551, 10.1161/CIRCULATIONAHA.113.005015

Shankman, 2015, KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis, Nat. Med., 21, 628, 10.1038/nm.3866

Feil, 2014, Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis, Circ. Res., 115, 662, 10.1161/CIRCRESAHA.115.304634

Stary, 1987, Macrophages, macrophage foam cells, and eccentric intimal thickening in the coronary arteries of young children, Atherosclerosis., 64, 91, 10.1016/0021-9150(87)90234-6

Wissler, 1990, The contribution of studies of atherosclerotic lesions in young people to future research, Ann. N. Y. Acad. Sci., 598, 418, 10.1111/j.1749-6632.1990.tb42313.x

Campbell, 1983, Lipid accumulation in arterial smooth muscle cells. Influence of phenotype, Atherosclerosis, 47, 279, 10.1016/0021-9150(83)90059-X

Argmann, 2004, Human smooth muscle cell subpopulations differentially accumulate cholesteryl ester when exposed to native and oxidized lipoproteins, Arterioscler. Thromb. Vasc. Biol., 24, 1290, 10.1161/01.ATV.0000131260.80316.37

Allahverdian, 2012, Contribution of monocyte-derived macrophages and smooth muscle cells to arterial foam cell formation, Cardiovasc. Res., 95, 165, 10.1093/cvr/cvs094

Ma, 2011, Activation of TRPV1 reduces vascular lipid accumulation and attenuates atherosclerosis, Cardiovasc. Res., 92, 504, 10.1093/cvr/cvr245

Stary, 1995, A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association, Circulation., 92, 1355, 10.1161/01.CIR.92.5.1355

Rong, 2003, Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading, Proc. Natl. Acad. Sci. U. S. A., 100, 13531, 10.1073/pnas.1735526100

Higashimori, 2011, Role of toll-like receptor 4 in intimal foam cell accumulation in apolipoprotein E-deficient mice, Arterioscler. Thromb. Vasc. Biol., 31, 50, 10.1161/ATVBAHA.110.210971

Ruan, 2006, Mechanisms of dysregulation of low-density lipoprotein receptor expression in vascular smooth muscle cells by inflammatory cytokines, Arterioscler. Thromb. Vasc. Biol., 26, 1150, 10.1161/01.ATV.0000217957.93135.c2

Matsumoto, 2000, Arterioscler. Thromb. Vasc. Biol., 20, 1027, 10.1161/01.ATV.20.4.1027

Wagsater, 2004, The chemokine and scavenger receptor CXCL16/SR-PSOX is expressed in human vascular smooth muscle cells and is induced by interferon gamma, Biochem. Biophys. Res. Commun., 325, 1187, 10.1016/j.bbrc.2004.10.160

Hoff, 1991, Lesion-derived low density lipoprotein and oxidized low density lipoprotein share a lability for aggregation, leading to enhanced macrophage degradation, Arterioscler. Thromb. a J. Vasc. Biol., 11, 1209, 10.1161/01.ATV.11.5.1209

Llorente-Cortes, 2000, LDL receptor-related protein mediates uptake of aggregated LDL in human vascular smooth muscle cells, Arterioscler. Thromb. Vasc. Biol., 20, 1572, 10.1161/01.ATV.20.6.1572

Llorente-Cortes, 2002, Human coronary smooth muscle cells internalize versican-modified LDL through LDL receptor-related protein and LDL receptors, Arterioscler. Thromb. Vasc. Biol., 22, 387, 10.1161/hq0302.105367

Llorente-Cortes, 2002, Differential role of heparan sulfate proteoglycans on aggregated LDL uptake in human vascular smooth muscle cells and mouse embryonic fibroblasts, Arterioscler. Thromb. Vasc. Biol., 22, 1905, 10.1161/01.ATV.0000035391.46201.9A

Llorente-Cortes, 2002, Low-density lipoprotein upregulates low-density lipoprotein receptor-related protein expression in vascular smooth muscle cells: possible involvement of sterol regulatory element binding protein-2-dependent mechanism, Circulation., 106, 3104, 10.1161/01.CIR.0000041434.28573.0B

Llorente-Cortes, 2004, Intra-cellular lipid accumulation, low-density lipoprotein receptor-related protein expression, and cell survival in vascular smooth muscle cells derived from normal and atherosclerotic human coronaries, Eur. J. Clin. Investig., 34, 182, 10.1111/j.1365-2362.2004.01316.x

Choi, 2009, Lipoprotein accumulation in macrophages via toll-like receptor-4-dependent fluid phase uptake, Circ. Res., 104, 1355, 10.1161/CIRCRESAHA.108.192880

Vengrenyuk, 2015, Cholesterol loading reprograms the microRNA-143/145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype, Arterioscler. Thromb. Vasc. Biol., 35, 535, 10.1161/ATVBAHA.114.304029

Wang, 2014, 17beta-estradiol promotes cholesterol efflux from vascular smooth muscle cells through a liver X receptor alpha-dependent pathway, Int. J. Mol. Med., 33, 550, 10.3892/ijmm.2014.1619

Ollikainen, 2016, Smooth muscle cell foam cell formation, apolipoproteins, and ABCA1 in intracranial aneurysms: implications for lipid accumulation as a promoter of aneurysm wall rupture, J. Neuropathol. Exp. Neurol., 75, 689, 10.1093/jnen/nlw041

Stukas, 2012, The LXR agonist GW3965 increases apoA-I protein levels in the central nervous system independent of ABCA1, Biochim. Biophys. Acta., 1821, 536, 10.1016/j.bbalip.2011.08.014

Beyea, 2012, The oxysterol 24(s),25-epoxycholesterol attenuates human smooth muscle-derived foam cell formation via reduced low-density lipoprotein uptake and enhanced cholesterol efflux, J. Am. Heart Assoc., 1, 10.1161/JAHA.112.000810

Li, 1993, Cholesterol is poorly available for free apolipoprotein-mediated cellular lipid efflux from smooth muscle cells, Biochemistry., 32, 4597, 10.1021/bi00068a016

Choi, 2009, ATP-binding cassette transporter A1 expression and apolipoprotein a-I binding are impaired in intima-type arterial smooth muscle cells, Circulation., 119, 3223, 10.1161/CIRCULATIONAHA.108.841130

Hoekstra, 2003, Specific gene expression of ATP-binding cassette transporters and nuclear hormone receptors in rat liver parenchymal, endothelial, and Kupffer cells, J. Biol. Chem., 278, 25448, 10.1074/jbc.M301189200

Hassan, 2006, Cellular cholesterol homeostasis in vascular endothelial cells, Can. J. Cardiol., 22, 35B, 10.1016/S0828-282X(06)70985-0

von Eckardstein, 2009, Transendothelial lipoprotein transport and regulation of endothelial permeability and integrity by lipoproteins, Curr. Opin. Lipidol., 20, 197, 10.1097/MOL.0b013e32832afd63

Hegyi, 2016, Functional Cooperativity between ABCG4 and ABCG1 isoforms, PLoS One, 11, 10.1371/journal.pone.0156516

Cavelier, 2006, ATP-binding cassette transporter A1 modulates apolipoprotein a-I transcytosis through aortic endothelial cells, Circ. Res., 99, 1060, 10.1161/01.RES.0000250567.17569.b3

Rohrer, 2009, High-density lipoprotein transport through aortic endothelial cells involves scavenger receptor BI and ATP-binding cassette transporter G1, Circ. Res., 104, 1142, 10.1161/CIRCRESAHA.108.190587

Navab, 2011, HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms, Nat. Rev. Cardiol., 8, 222, 10.1038/nrcardio.2010.222

Savion, 1989, Cholesterol efflux from and high-density-lipoproteins binding to cultured bovine vascular endothelial cells are higher than with vascular smooth muscle cells, Eur. J. Biochem., 183, 363, 10.1111/j.1432-1033.1989.tb14937.x

Vaisman, 2012, Endothelial expression of human ABCA1 in mice increases plasma HDL-C and reduces diet-induced atherosclerosis, J. Lipid Res., 53, 158, 10.1194/jlr.M018713

Terasaka, 2008, ABCG1 and HDL protect against endothelial dysfunction in mice fed a high-cholesterol diet, J. Clin. Invest., 118, 3701, 10.1172/JCI35470

Westerterp, 2016, Deficiency of ATP-binding cassette transporters A1 and G1 in endothelial cells accelerates atherosclerosis in mice, Arterioscler. Thromb. Vasc. Biol., 36, 1328, 10.1161/ATVBAHA.115.306670

Münch, 2012, Overexpression of ABCG1 protein attenuates arteriosclerosis and endothelial dysfunction in atherosclerotic rabbits, Heart Int., 7, e12, 10.4081/hi.2012.e12

Westerterp, 2010, Increased atherosclerosis in mice with vascular ATP-binding cassette transporter G1 deficiency--brief report, Arterioscler. Thromb. Vasc. Biol., 30, 2103, 10.1161/ATVBAHA.110.212985

Huang, 2014, An abundant dysfunctional apolipoprotein A1 in human atheroma, Nat. Med., 20, 193, 10.1038/nm.3459

Inzucchi, 2012, Clinical practice. Diagnosis of diabetes, N. Engl. J. Med., 367, 542, 10.1056/NEJMcp1103643

Drexel, 2005, Is atherosclerosis in diabetes and impaired fasting glucose driven by elevated LDL cholesterol or by decreased HDL-C?, Diabetes Care, 28, 101, 10.2337/diacare.28.1.101

Hwang, 2015, Differential association between HDL subclasses and the development of type 2 diabetes in a prospective study of japanese americans, Diabetes Care, 38, 2100, 10.2337/dc15-0625

Abbasi, 2013, Role of HDL-C and estimates of HDL particle composition in future development of type 2 diabetes in the general population: the PREVEND study, J. Clin. Endocrinol. Metab., 98, E1352, 10.1210/jc.2013-1680

Nieuwdorp, 2008, Reconstituted HDL infusion restores endothelial function in patients with type 2 diabetes mellitus, Diabetologia., 51, 1081, 10.1007/s00125-008-0975-2

Patel, 2009, Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes, J. Am. Coll. Cardiol., 53, 962, 10.1016/j.jacc.2008.12.008

Brites, 1999, Abnormal capacity to induce cholesterol efflux and a new LpA-I pre-beta particle in type 2 diabetic patients, Clin. Chim. Acta, 279, 1, 10.1016/S0009-8981(98)00155-7

Fielding, 1982, Human noninsulin-dependent diabetes: identification of a defect in plasma cholesterol transport normalized in vivo by insulin and in vitro by selective immunoadsorption of apolipoprotein E, Proc. Natl. Acad. Sci. U. S. A., 79, 6365, 10.1073/pnas.79.20.6365

Wang, 2002, Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette transporter A1, J. Biol. Chem., 277, 5692, 10.1074/jbc.M109977200

Tang, 2010, Diabetes reduces the cholesterol exporter ABCA1 in mouse macrophages and kidneys, J. Lipid Res., 51, 1719, 10.1194/jlr.M003525

Forcheron, 2002, Mechanisms of the triglyceride- and cholesterol-lowering effect of fenofibrate in hyperlipidemic type 2 diabetic patients, Diabetes., 51, 3486, 10.2337/diabetes.51.12.3486

Ohgami, 2001, Scavenger receptor class B type I-mediated reverse cholesterol transport is inhibited by advanced glycation end products, J. Biol. Chem., 276, 13348, 10.1074/jbc.M011613200

Miyazaki, 2002, Scavenger receptors that recognize advanced glycation end products, Trends Cardiovasc. Med., 12, 258, 10.1016/S1050-1738(02)00171-8

Apro, 2016, Impaired cholesterol efflux capacity of high-density lipoprotein isolated from interstitial fluid in type 2 diabetes mellitus-brief report, Arterioscler. Thromb. Vasc. Biol., 36, 787, 10.1161/ATVBAHA.116.307385

Autran, 2000, Postprandial reverse cholesterol transport in type 2 diabetic patients: effect of a lipid lowering treatment, Atherosclerosis., 153, 453, 10.1016/S0021-9150(00)00428-7

Attia, 2007, Increased phospholipid transfer protein activity associated with the impaired cellular cholesterol efflux in type 2 diabetic subjects with coronary artery disease, Tohoku J. Exp. Med., 213, 129, 10.1620/tjem.213.129

Kubota, 2014, Relationship between serum cholesterol efflux capacity and glucose intolerance in Japanese-Americans, J. Atheroscler. Thromb., 21, 1087, 10.5551/jat.24315

Machado-Lima, 2015, In type 2 diabetes mellitus glycated albumin alters macrophage gene expression impairing ABCA1-mediated cholesterol efflux, J. Cell. Physiol., 230, 1250, 10.1002/jcp.24860

Blanco-Rojo, 2017, HDL-C efflux normalised to apoA-I is associated with future development of type 2 diabetes: from the CORDIOPREV trial, Sci. Rep., 7, 12499, 10.1038/s41598-017-12678-9

Oram, 2006, ATP-binding cassette cholesterol transporters and cardiovascular disease, Circ. Res., 99, 1031, 10.1161/01.RES.0000250171.54048.5c

Fryirs, 2010, Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion, Arterioscler. Thromb. Vasc. Biol., 30, 1642, 10.1161/ATVBAHA.110.207373

Brunham, 2007, Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment, Nat. Med., 13, 340, 10.1038/nm1546

Kruit, 2011, Islet cholesterol accumulation due to loss of ABCA1 leads to impaired exocytosis of insulin granules, Diabetes., 60, 3186, 10.2337/db11-0081

Hao, 2007, Direct effect of cholesterol on insulin secretion: a novel mechanism for pancreatic beta-cell dysfunction, Diabetes., 56, 2328, 10.2337/db07-0056

Lee, 2011, Cholesterol elevation impairs glucose-stimulated ca (2+) signaling in mouse pancreatic β-cells, Endocrinology., 152, 3351, 10.1210/en.2011-0124

Kang, 2013, Regulation of ABCA1 protein expression and function in hepatic and pancreatic islet cells by miR-145, Arterioscler. Thromb. Vasc. Biol., 33, 2724, 10.1161/ATVBAHA.113.302004

Wijesekara, 2012, miR-33a modulates ABCA1 expression, cholesterol accumulation, and insulin secretion in pancreatic islets, Diabetes., 61, 653, 10.2337/db11-0944

Kruit, 2010, HDL and LDL cholesterol significantly influence beta-cell function in type 2 diabetes mellitus, Curr. Opin. Lipidol., 21, 178, 10.1097/MOL.0b013e328339387b

Villarreal-Molina, 2007, The ATP-binding cassette transporter A1 R230C variant affects HDL-C levels and BMI in the Mexican population: association with obesity and obesity-related comorbidities, Diabetes, 56, 1881, 10.2337/db06-0905

Mauldin, 2006, Reduction in ABCG1 in type 2 diabetic mice increases macrophage foam cell formation, J. Biol. Chem., 281, 21216, 10.1074/jbc.M510952200

Daffu, 2015, RAGE suppresses ABCG1-mediated macrophage cholesterol efflux in diabetes, Diabetes., 64, 4046, 10.2337/db15-0575

Drew, 2009, High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus, Circulation., 119, 2103, 10.1161/CIRCULATIONAHA.108.843219

Rutti, 2009, Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic beta-cells, Endocrinology., 150, 4521, 10.1210/en.2009-0252

Dietschy, 2001, Cholesterol metabolism in the brain, Curr. Opin. Lipidol., 12, 105, 10.1097/00041433-200104000-00003

Bjorkhem, 2004, Brain cholesterol: long secret life behind a barrier, Arterioscler. Thromb. Vasc. Biol., 24, 806, 10.1161/01.ATV.0000120374.59826.1b

Wang, 2014, What are lipoproteins doing in the brain?, Trends Endocrinol. Metab., 25, 8, 10.1016/j.tem.2013.10.003

Vitali, 2014, HDL and cholesterol handling in the brain, Cardiovasc. Res., 103, 405, 10.1093/cvr/cvu148

Ladu, 2000, Lipoproteins in the central nervous system, Ann. N. Y. Acad. Sci., 903, 167, 10.1111/j.1749-6632.2000.tb06365.x

Vance, 2012, Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases, Dis. Model. Mech., 5, 746, 10.1242/dmm.010124

Björkhem, 1998, Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation, J. Lipid Res., 39, 1594, 10.1016/S0022-2275(20)32188-X

Kessel, 2001, Interactions of cholesterol with lipid bilayers: the preferred configuration and fluctuations, Biophys. J., 81, 643, 10.1016/S0006-3495(01)75729-3

Meaney, 2002, On the rate of translocation in vitro and kinetics in vivo of the major oxysterols in human circulation: critical importance of the position of the oxygen function, J. Lipid Res., 43, 2130, 10.1194/jlr.M200293-JLR200

Balazs, 2004, Uptake and transport of high-density lipoprotein (HDL) and HDL-associated alpha-tocopherol by an in vitro blood-brain barrier model, J. Neurochem., 89, 939, 10.1111/j.1471-4159.2004.02373.x

Mauch, 2001, CNS synaptogenesis promoted by glia-derived cholesterol, Science., 294, 1354, 10.1126/science.294.5545.1354

Wang, 2014, Lipid rafts: a signaling platform linking cholesterol metabolism to synaptic deficits in autism spectrum disorders, Front. Behav. Neurosci., 8, 104, 10.3389/fnbeh.2014.00104

Di Paolo, 2011, Linking lipids to Alzheimer's disease: cholesterol and beyond, Nat. Rev. Neurosci., 12, 284, 10.1038/nrn3012

Van Hove, 2010, Succinyl-CoA ligase deficiency: a mitochondrial hepatoencephalomyopathy, Pediatr. Res., 68, 159, 10.1203/PDR.0b013e3181e5c3a4

Wanders, 2006, Biochemistry of mammalian peroxisomes revisited, Annu. Rev. Biochem., 75, 295, 10.1146/annurev.biochem.74.082803.133329

Chen, 2013, Cholesterol efflux is differentially regulated in neurons and astrocytes: implications for brain cholesterol homeostasis, Biochim. Biophys. Acta, 1831, 263, 10.1016/j.bbalip.2012.09.007

Vance, 2010, Formation and function of apolipoprotein E-containing lipoproteins in the nervous system, Biochim. Biophys. Acta, 1801, 806, 10.1016/j.bbalip.2010.02.007

Pitas, 1987, Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E (LDL) receptors in the brain, J. Biol. Chem., 262, 14352, 10.1016/S0021-9258(18)47945-8

Kim, 2007, Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generation, J. Biol. Chem., 282, 2851, 10.1074/jbc.M607831200

Fu, 2015, ABCA5 regulates amyloid-beta peptide production and is associated with Alzheimer's disease neuropathology, J. Alzheimers Dis., 43, 857, 10.3233/JAD-141320

Fagan, 1999, Unique lipoproteins secreted by primary astrocytes from wild type, apoE (−/−), and human apoE transgenic mice, J. Biol. Chem., 274, 30001, 10.1074/jbc.274.42.30001

LaDu, 1998, Nascent astrocyte particles differ from lipoproteins in CSF, J. Neurochem., 70, 2070, 10.1046/j.1471-4159.1998.70052070.x

Ebberink, 2011, Genetic classification and mutational spectrum of more than 600 patients with a Zellweger syndrome spectrum disorder, Hum. Mutat., 32, 59, 10.1002/humu.21388

Perl, 2010, Neuropathology of Alzheimer's disease, Mt Sinai J. Med., 77, 32, 10.1002/msj.20157

Koudinov, 1998, Alzheimer's amyloid beta interaction with normal human plasma high density lipoprotein: association with apolipoprotein and lipids, Clin. Chim. Acta., 270, 75, 10.1016/S0009-8981(97)00207-6

Handattu, 2009, Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer's disease, Neurobiol. Dis., 34, 525, 10.1016/j.nbd.2009.03.007

Cui, 2016, D-4F decreases white matter damage after stroke in mice, Stroke., 47, 214, 10.1161/STROKEAHA.115.011046

Buga, 2006, D-4F decreases brain arteriole inflammation and improves cognitive performance in LDL receptor-null mice on a Western diet, J. Lipid Res., 47, 2148, 10.1194/jlr.M600214-JLR200

Song, 2014, Lipoprotein-based nanoparticles rescue the memory loss of mice with Alzheimer's disease by accelerating the clearance of amyloid-beta, ACS Nano, 8, 2345, 10.1021/nn4058215

Roma, 1993, In vivo metabolism of a mutant form of apolipoprotein A-I, apo A-IMilano, associated with familial hypoalphalipoproteinemia, J. Clin. Invest., 91, 1445, 10.1172/JCI116349

Lewis, 2010, Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease, J. Biol. Chem., 285, 36958, 10.1074/jbc.M110.127829

DeMattos, 2001, Peripheral anti-a beta antibody alters CNS and plasma a beta clearance and decreases brain a beta burden in a mouse model of Alzheimer's disease, Proc. Natl. Acad. Sci. U. S. A., 98, 8850, 10.1073/pnas.151261398

Fitz, 2015, Opposing effects of Apoe/Apoa1 double deletion on amyloid-β pathology and cognitive performance in APP mice, Brain., 138, 3699, 10.1093/brain/awv293

Thanopoulou, 2010, Scavenger receptor class B type I (SR-BI) regulates perivascular macrophages and modifies amyloid pathology in an Alzheimer mouse model, Proc. Natl. Acad. Sci. U. S. A., 107, 20816, 10.1073/pnas.1005888107

Koldamova, 2005, Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice, J. Biol. Chem., 280, 43224, 10.1074/jbc.M504513200

Wahrle, 2005, Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease, J. Biol. Chem., 280, 43236, 10.1074/jbc.M508780200

Hirsch-Reinshagen, 2005, The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease, J. Biol. Chem., 280, 43243, 10.1074/jbc.M508781200

Koldamova, 2003, 22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion, J. Biol. Chem., 278, 13244, 10.1074/jbc.M300044200

Lupton, 2014, The role of ABCA1 gene sequence variants on risk of Alzheimer's disease, J. Alzheimers Dis., 38, 897, 10.3233/JAD-131121

Hong, 2014, Liver X receptors in lipid metabolism: opportunities for drug discovery, Nat. Rev. Drug Discov., 13, 433, 10.1038/nrd4280

Brunham, 2006, Tissue-specific induction of intestinal ABCA1 expression with a liver X receptor agonist raises plasma HDL-C levels, Circ. Res., 99, 672, 10.1161/01.RES.0000244014.19589.8e

Zelcer, 2007, Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors, Proc. Natl. Acad. Sci. U. S. A., 104, 10601, 10.1073/pnas.0701096104

Yassine, 2016, ABCA1-mediated cholesterol efflux capacity to cerebrospinal fluid Is reduced in patients with mild cognitive impairment and alzheimer's disease, J. Am. Heart Assoc., 5, 10.1161/JAHA.115.002886

Fitz, 2012, Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice, J. Neurosci., 32, 13125, 10.1523/JNEUROSCI.1937-12.2012

Pereira, 2018, ABC transporters are key players in alzheimer's disease, J. Alzheimers. Dis., 61, 463, 10.3233/JAD-170639

Fukumoto, 2002, Induction of the cholesterol transporter ABCA1 in central nervous system cells by liver X receptor agonists increases secreted Abeta levels, J. Biol. Chem., 277, 48508, 10.1074/jbc.M209085200

Elliott, 2010, Apolipoproteins in the brain: implications for neurological and psychiatric disorders, Clin. Lipidol., 51, 555, 10.2217/clp.10.37

Huang, 2008, Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues, Mol. Psychiatry, 13, 1118, 10.1038/sj.mp.4002108

Stukas, 2014, Intravenously injected human apolipoprotein A-I rapidly enters the central nervous system via the choroid plexus, J. Am. Heart Assoc., 3, 10.1161/JAHA.114.001156

Fung, 2017, SR-BI mediated transcytosis of HDL in brain microvascular endothelial cells is independent of caveolin, clathrin, and PDZK1, Front. Physiol., 8, 841, 10.3389/fphys.2017.00841

Abuznait, 2012, Role of ABC transporters in the pathogenesis of Alzheimer's disease, ACS Chem. Neurosci., 3, 820, 10.1021/cn300077c

Zhang, 2012, Proteolytic processing of Alzheimer's beta-amyloid precursor protein, J. Neurochem., 120, 9, 10.1111/j.1471-4159.2011.07519.x

Wolf, 2012, ABC transporters and the Alzheimer's disease enigma, Front. Psychiatry., 3, 54, 10.3389/fpsyt.2012.00054

Holtzman, 2001, Role of apoe/Abeta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy, J. Mol. Neurosci., 17, 147, 10.1385/JMN:17:2:147

Deane, 2008, apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain, J. Clin. Invest., 118, 4002, 10.1172/JCI36663

Roses, 1996, Apolipoprotein E alleles as risk factors in Alzheimer's disease, Annu. Rev. Med., 47, 387, 10.1146/annurev.med.47.1.387

Ye, 2005, Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target, Proc. Natl. Acad. Sci. U. S. A., 102, 18700, 10.1073/pnas.0508693102

Tai, 2017, EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimer's disease, J. Lipid Res., 58, 1733, 10.1194/jlr.R076315

Verghese, 2013, ApoE influences amyloid-beta (Abeta) clearance despite minimal apoE/Abeta association in physiological conditions, Proc. Natl. Acad. Sci. U. S. A., 110, E1807, 10.1073/pnas.1220484110

Castellano, 2011, Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance, Sci. Transl. Med., 3, 89ra57, 10.1126/scitranslmed.3002156

Ishikawa, 2015, High-density lipoprotein cholesterol efflux capacity as a relevant predictor of atherosclerotic coronary disease, Atherosclerosis., 242, 318, 10.1016/j.atherosclerosis.2015.06.028

Nicholls, 2015, Cholesterol efflux capacity and pre-Beta-1 HDL concentrations are increased in dyslipidemic patients treated with evacetrapib, J. Am. Coll. Cardiol., 66, 2201, 10.1016/j.jacc.2015.09.013

Yvan-Charvet, 2010, Cholesterol efflux potential and antiinflammatory properties of high-density lipoprotein after treatment with niacin or anacetrapib, Arterioscler. Thromb. Vasc. Biol., 30, 1430, 10.1161/ATVBAHA.110.207142